Skip to main content
Signal8

AREV Life Sciences Global Corp (AREVF)

AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient supplementation. It also develops edible oils, moringa, hops, cannabis sativa, pharma, sea cucumber, ginseng, and functional fungi ingredients; and anti-virals and phytomedicinalization. In addition, the company flash-freezes active ingredients, oils, and oleoresins for use as ingredients in food, nutraceuticals, and other consumer products. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. is based in Coquitlam, Canada.

Sector: Medical - Pharmaceuticals

Industry: Medical - Pharmaceuticals

AREV Life Sciences Global Corp logo

AREV Life Sciences Global Corp

OTC:AREVFHealthcare
Mkt Cap-
EV-
Float16.83M
O/S31.76M
Inst Own-
Net Cash/Sh-$0.00
Dilution
Financials Summary
Revenue$34K
Net Income-$1.01M
Total Assets$177K
Free Cash Flow-$256K
Debt & Equity
Total Debt$20K
Total Equity-$667K
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:6Reverse split
    Mar 19, 20206 shares → 1
Balance Sheet Details
Assets$177K
Liabilities$844K
Accounts Receivable$34K
Accounts Payable$564K
Inventory$0
PP&E (Net)$130K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue$34K$179K$133K$136K$0$0$0$0$0$0$0$72K$28K$0$210K
YoY Growth-80.7%33.8%-2.1%--------162.1%---
Cost of Revenue$14K$49K$0$46K$37K$36K$5K$249$31K$0$0$9K$8K$0$79K
Gross Profit$20K$130K$133K$90K-$37K-$36K-$5K-$249-$31K$0$0$63K$19K$0$131K
Gross Margin59.3%72.6%100.0%66.3%-------87.3%69.8%-62.4%
Research and Development$59K$104K$90K$804K$137K$0$0$0$0$0$0$0$0$27K$94K
Selling, General, and Administrative$834K$1.14M$397K$1.4M$1.15M$541K$153K$57K$21K$23K$34K$20K$40K$140K$198K
Other$11K-$65K-$37K$46K-$29K$0$0$0$0$0$0$0$0$0$0
Total Operating Expenses$905K$1.18M$450K$2.25M$1.18M$577K$158K$57K$21K$24K$34K$20K$50K$167K$292K
Operating Income (EBIT)-$972K-$1.05M-$317K-$2.12M-$1.18M-$594K-$158K-$57K-$21K-$24K-$34K$43K-$31K-$175K-$161K
Operating Margin-2827.7%-587.0%-237.3%-1554.4%-------59.8%-112.3%--76.7%
Interest Expense$4K$32K$41K$51K$28K$26K$18K$2K$214$135$111$172$641$0$638
Interest Income$0$0$0$0$0$0$0$0$0$0$0$0$0$876$5K
Other Income (Expense)-$127K$355K-$418K-$117K-$4.72M-$157K-$18K-$2K-$9K-$135-$111-$172$19K$17K$4K
Income Before Tax (EBT)-$1.01M-$693K-$734K-$2.24M-$5.9M-$714K-$176K-$59K-$53K-$24K-$34K$43K-$12K-$158K-$157K
Income Tax Expense$0$0$0$0$28K$8K$0$0$214$0$0$0$0$0$0
Net Income-$1.01M-$693K-$734K-$2.24M-$5.9M-$714K-$176K-$59K-$53K-$24K-$34K$43K-$12K-$158K-$157K
Net Income Margin-2940.4%-388.4%-550.4%-1640.0%-------59.6%-41.8%--74.7%
Supplementary Data
EPS-0.05-0.04-0.07-0.36-1.47-0.42-24.40-16.45-13.07-6.23-7.579.75-2.80-38.28-37.97
Diluted EPS-0.05-0.05-0.07-0.36-1.47-0.42-24.40-16.45-13.07-6.23-7.579.75-2.80-38.28-37.97
Weighted Average OS30.07M27.47M15.36M8.96M5.73M2.42M10,3125,1175,7565,4576,4686,3285,9025,9025,902
EBITDA-$917K-$558K-$317K-$2.14M-$1.15M-$558K-$153K-$57K-$21K-$23K-$34K$44K-$31K-$175K-$160K
EBITDA Margin-2668.7%-312.8%-237.3%-1568.7%-------60.1%-111.6%--76.3%
Balance Sheet
PeriodFY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Assets
Current Assets
Cash and Cash Equivalents$66$111K$208K$21K$6K$741K$136K$1K$1K$4K$24K$14K$7K$4K$56K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$66$111K$208K$21K$6K$741K$136K$1K$1K$4K$24K$14K$7K$4K$56K
Accounts Receivable$34K$90K$19K$2K$0$0$0$0$0$867$2K$52K$6K$17K$84K
Inventory$0$14K$3K$0$0$29K$16K$0-$986$31K$31K$31K$42K$51K$51K
Other Current Assets$0$0$361K$13K$0$0$0$0$0$0$0$0$0$0$0
Total Current Assets$47K$237K$601K$60K$371K$834K$171K$10K$2K$37K$58K$97K$55K$72K$201K
Long-Term Assets
Property, Plant & Equipment Net$130K$199K$293K$556K$0$327K$281K$2K$0$398$576$755$933$1K$2K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$104K$0$0$0$0$0$0$0$14K
Long-Term Investments$0$0$0$9K$9K$26K$4K$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0-$9K-$9K-$26K-$4K$0$0$0$0$0$0$0$12K
Total Long-Term Assets$130K$199K$293K$556K$2$327K$385K$2K$0$398$576$755$933$1K$28K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$177K$436K$894K$616K$371K$1.16M$556K$12K$2K$37K$58K$98K$56K$73K$229K
Liabilities
Current Liabilities
Accounts Payable$564K$333K$303K$215K$126K$221K$93K$35K$11K$315$937$1K$13K$68K$52K
Short-Term Debt$20K$16K$445K$401K$299K$199K$0$0$0$0$0$0$18K$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$2K$0$0$0
Current Unearned Revenue$0$0$0$0$0-$199K-$11K$0$0$0$0$0$0$0$0
Other Current Liabilities$0-$25K$0$0$31K$0$0$0$0$0$0$0$0$0$0
Total Current Liabilities$844K$501K$1.31M$984K$530K$290K$173K$127K$59K$40K$38K$44K$63K$68K$66K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$199K$254K$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0-$199K$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$0$0$37K$0$0$199K$254K$0$0$0$0$0$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$844K$501K$1.34M$984K$530K$490K$427K$127K$59K$40K$38K$44K$63K$68K$66K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$9.57M$9.21M$8.43M$7.92M$6.75M$2.13M$905K$523K$523K$523K$0$0$0$0$0
Retained Earnings-$12.28M-$11.27M-$10.58M-$9.85M-$7.72M-$1.82M-$1.11M-$934K-$875K-$822K-$799K-$764K-$808K-$796K-$638K
Comprehensive Income & Other$71K$2M$93$178$92$396K$296K$296K$0$0$0$0$0$0$0
Other Stockholders' Equity$2.05M$2M$1.7M$1.56M$810K$369K$334K$296K$296K$296K$819K$819K$801K$801K$801K
Total Equity-$667K-$65K-$449K-$368K-$159K$671K$129K-$115K-$56K-$3K$20K$55K-$7K$5K$163K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$177K$436K$894K$616K$371K$1.16M$556K$12K$2K$37K$58K$98K$56K$73K$229K
Supplementary Data
Total Debt$20K$53K$515K$401K$299K$199K$254K$36K$0$0$0$0$18K$0$0
Net Debt$20K-$58K$307K$380K$294K-$542K$118K$35K-$1K-$4K-$24K-$14K$11K-$4K-$56K
Cash Flow Statement
PeriodFY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Operating Activities
Net Income-$1.01M-$693K-$734K-$2.24M-$5.9M-$714K-$176K-$59K-$53K-$24K-$34K$43K-$12K-$158K-$157K
Depreciation & Amortization$88K$103K$104K$46K$37K$36K$5K$249$179$179$179$179$179$641$798
Deferred Income Tax$0-$566K$196K$65K$4.68M$101K$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$101K$319K$74K$743K$432K$138K$25K$0$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$53K-$2K-$3K-$24K$9K-$20K-$4K-$2K$0$333$52K-$50K$9K$74K-$69K
  Inventory$0-$14K-$3K$24K$0-$13K-$16K$0$0$0$0$11K$8K$70-$51K
  Accounts Payable$389K$104K$125K$253K-$151K$107K$0$0$0$0$0$0$0$0$0
  Other Working Capital$154K-$347K$178K$181K$9K$68K$84K$27K$18K$3K-$7K$3K-$679$14K$14K
Total Working Capital Change$595K-$259K$297K$434K-$142K$108K$63K$25K$18K$4K$45K-$37K$16K$88K-$106K
Other Non-Cash Items$28K$68K$47K$867K$25K$118K$6K$3K$32K$2K$0$0-$20K$16K$74K
Net Cash from Operating-$199K-$1.03M-$16K-$80K-$877K-$314K-$78K-$34K-$3K-$20K$10K$7K-$15K-$53K-$188K
Investing Activities
Capital Expenditures-$19K-$46K-$319K-$151K-$35K-$79K-$3K-$2K$0$0$0$0$0$0-$189
Acquisitions$0$42K$14K$0$20K$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$53K$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$14K$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities-$38K$8K-$67K$0-$284K$0$0$0$0$0$0$0$0$2K-$31K
Net Cash from Investing-$57K$4K-$305K-$151K-$299K-$79K-$3K-$2K$0$0$0$0$0$2K-$31K
Financing Activities
Debt Repaid-$4K-$220K$37K-$70K-----------
Common Stock Issuance$141K$466K$315K$175K$424K$819K$179K$0$0$0$0$0$0$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$142K$212K$231K$0$441K$179K$37K$0$0$0$0$332$0$0$0
Net Cash from Financing$146K$898K$509K$245K$441K$998K$216K$36K$0$0$0$332$18K$0-$50K
Forex Effect$36$25$0$85$92$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$111K-$98K$188K$15K-$735K$605K$135K$15-$3K-$20K$10K$7K$2K-$51K-$270K
Supplementary Data
Operating Cash Flow-$199K-$1.03M-$16K-$80K-$877K-$314K-$78K-$34K-$3K-$20K$10K$7K-$15K-$53K-$188K
Capital Expenditure-$57K-$8K-$319K-$151K-$35K-$79K-$3K-$2K$0$0$0$0$0$0-$189
Free Cash Flow-$256K-$1.04M-$336K-$230K-$912K-$393K-$81K-$36K-$3K-$20K$10K$7K-$15K-$53K-$189K
Cash at Beginning$111K$208K$21K$6K$741K$136K$1K$1K$4K$24K$14K$7K$4K$56K$325K
Cash at End$66$111K$208K$21K$6K$741K$136K$1K$1K$4K$24K$14K$7K$4K$56K